Overexpression of P2X7R has been observed in several tumours and is related to cancer advancement and metastasis. However, the role of P2X7R in colorectal cancer (CRC) patients is not well understood. In the current study, overexpression of P2X7R and the effects at the molecular and functional levels in CRC were assessed in a mouse orthotopic model. Functional assays, such as the CCKâ8 assay, wound healing and transwell assay, were used to determine the biological role of P2X7R in CRC cells. CSCârelated genes and properties were detected via sphere formation and realâtime PCR assays. The underlying mechanisms were explored by Western blotting, realâtime PCR and Flow cytometry. In this study, we found that overexpression of P2X7R increases in the in vivo growth of tumours. P2X7R overexpression also increased CD31, VEGF and concurrent angiogenesis. P2X7R upâregulates aldehyde dehydrogenaseâ1 (ALDH1) and CSC characteristics. Transplanted tumour cells with P2X7R overexpression stimulated cytokines to recruit tumourâassociated macrophage (TAMs) to increase the growth of tumours. We also found that the NFâÎșB signalling pathway is involved in P2X7Râinduced cytokine upâregulation. P2X7R promotes NFâÎșBâdependent cytokine induction, which leads to TAM recruitment to control tumour growth and advancement and remodelling of the stroma. Our findings demonstrate that P2X7R plays a key role in TAM recruitment, which may be a therapeutic target for CRC patients.